The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030, claims Roots Analysis
October 26, 2021 09:15 ET
|
Roots Analysis
London, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings. Success of approved...
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
November 09, 2020 08:00 ET
|
Checkpoint Therapeutics, Inc
44.0% objective response rate and 10.3-month median progression-free survival observed in non-small cell lung cancer (NSCLC) cohortPhase 3 registration-enabling trial planned in first-line metastatic...
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
September 05, 2019 08:30 ET
|
Genprex, Inc.
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights
July 26, 2019 11:03 ET
|
Fortune Business Insights
Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small...
Non-Small Cell Lung Cancer Market To Reach USD 10.53 Billion By 2026 | Reports And Data
June 05, 2019 11:51 ET
|
Reports And Data
Increase in the understanding of diseases and research into the development of new drugs for non-small cell lung cancer is fueling the market growth. Market Size – USD 6.45 Billion in 2018, Market...
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
May 31, 2019 08:30 ET
|
Genprex, Inc.
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully...
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
May 09, 2019 08:30 ET
|
Genprex, Inc.
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
May 08, 2019 08:30 ET
|
Genprex, Inc.
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
April 12, 2019 09:00 ET
|
Genprex, Inc.
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- GNPX)">Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene...
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
April 11, 2019 08:30 ET
|
Genprex, Inc.
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — GNPX)">Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted...